Medications for Opioid Use Disorders and Hepatitis C: Access and Adherence Among People Who Inject Drugs (webinar)
June 26, 2019
Hepatitis C virus is on the rise in rural communities of the U.S. This presentation from Judith Tsui, MD, MPH (University of Washington School of Medicine) described the syndemic of opioid use disorder (OUD) and hepatitis C (HCV). Dr. Tsui presented evidence showing the current gaps in treatment for OUD and HCV among persons who inject drugs. Based on analysis of current treatment methods and real-world patient living conditions, her presentation also described research on innovative models of care to improve treatment access and outcomes for persons with OUD and HCV.
This webinar was sponsored by the Northwest ATTC and the Area Health Education Center for Western Washington (AHECWW).